Close

Analyst Ratings for Amicus Therapeutics (FOLD) [Neutrals]

FOLD Rating Summary

FOLD Price Target Summary

* Over Last 12-Mos
  |   Expand Research on FOLD
Overall Rating: BUY   Rating Trend: Up   Avg. $ Target: $18.20 (+76.2%) * Over Last 12-Mos
Rating Score: 6.7 / 10   Percentile Rank: 72%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
1/13/2023 Jefferies Vedvati Shrote New Coverage Hold
(N/A)
N/A
(N/A)
12.02
(10.33)
-14.06% Details
4/13/2022 Goldman Sachs
» Updated 3/2/2023
Salveen Richter New Coverage Neutral
(N/A)
11.00
(10.00)
8.38
(10.33)
23.27% Details